Last reviewed · How we verify

NCT06810921

Lateral Sinus Augmentation Utilizing Bovine Bone Mixed with Platelet-rich Fibrin

Completed EARLY_PHASE1 Last updated 6 February 2025
What this trial tests

EARLY_PHASE1 trial testing lateral sinus lift in Lateral Sinus Lifting in 34 participants. Completed in 1 August 2024.

Timeline
13 January 2023
Primary endpoint
20 March 2024
1 August 2024

Quick facts

Lead sponsorUniversity of Baghdad
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment34
Start date13 January 2023
Primary completion20 March 2024
Estimated completion1 August 2024
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

University of Baghdad

Who can join

Eligibility, any sex, with Lateral Sinus Lifting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: In sinus augmentation procedure, graft resorption remains a major dilemma of various graft materials. Objective: To estimate the graft volume changes following lateral sinus augmentation utilizing cone beam computed tomography. Methods: A total of 34 lateral sinus augmentation operations were performed and 50 dental implants were concomitantly inserted. The sinus augmentation cases were distributed randomly into 3 groups according to graft material: Group A comprised utilizing deproteinized bovine bone alone, group B using deproteinized bovine bone mixed with leukocyte and platelet-rich fibrin, and group C employing deproteinized bovine bone mixed with advanced platelet-rich fibrin. Cone-beam computed tomography was obtained 2 weeks (baseline record) and 24 weeks postoperatively for the measurement of the graft volume changes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Baghdad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06810921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing